38 /100
MEDIUM RISK
Score updated Jul 13, 2026

NAN — Nuveen New York Quality Municipal Income Fund Dilution Risk Tracker

Track NAN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NAN — Get alerts when the score changes →

As of July 13, 2026, Nuveen New York Quality Municipal Income Fund (NAN) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. Nuveen New York Quality Municipal Income Fund has a market capitalization of $367.40M, 31.95M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NAN.
🔔 Track NAN — Get forecast alerts →

💹 Market Data

Market Cap$367.40M
Shares Outstanding31.95M
FloatN/A
Cash$6.92M
Debt$244.18M
Short InterestN/A

🏛 Institutional Holdings

15.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NAN for full holder detail →

📉 Short Interest

Short Interest322.6K
Days to Cover4.5
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for NAN Shareholders

Nuveen New York Quality Municipal Income Fund (NAN) has a DilutionScore of 38/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NAN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NAN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NAN alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NAN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NAN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NAN
📊 NAN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NAN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.